EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Entheon Biomedical's enterprise value is $0.92 Mil.
Entheon Biomedical's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 was $0.10 Mil. Therefore, Entheon Biomedical's EV-to-Revenue for today is 9.61.
The historical rank and industry rank for Entheon Biomedical's EV-to-Revenue or its related term are showing as below:
ENTBF'
s EV-to-Revenue Range Over the Past 10 Years
Min: -132.03 Med: 5.47 Max: 4512.37
Current: 9.66
During the past 7 years, the highest EV-to-Revenue of Entheon Biomedical was 4512.37. The lowest was -132.03. And the median was 5.47.
ENTBF's EV-to-Revenue is ranked worse than 54.61% of 1042
companies
in the Biotechnology industry
Industry Median: 8.155
vs ENTBF: 9.66
The historical data trend for Entheon Biomedical's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Entheon Biomedical's EV-to-Revenue
For the Biotechnology subindustry, Entheon Biomedical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Entheon Biomedical's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Entheon Biomedical's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Entheon Biomedical's EV-to-Revenue falls into.
Entheon Biomedical's current Enterprise Value is $0.92 Mil.
Entheon Biomedical's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.10 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Entheon Biomedical's share price for today is $0.131.
Entheon Biomedical's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Entheon Biomedical EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Entheon Biomedical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Entheon Biomedical (Entheon Biomedical) Business Description
Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ENTBF has been successfully added to your 